CytoDyn appoints Dr. Scott A. Kelly as chairman of the board
CytoDyn announces that its board of directors has appointed Scott A. Kelly, M.D., FAAPMR as chairman of the board. Dr. Kelly has served as a member of CytoDyn’s board since April 2017 and succeeds Anthony D. Caracciolo, who will continue to serve as a director of the Company. December 12, 2018